BR112014023195B1 - vacina contra o vírus sincicial respiratório (rsv), método para produção de uma vacina contra o vírus sincicial respiratório (rsv) e ácido nucleico recombinante isolado - Google Patents

vacina contra o vírus sincicial respiratório (rsv), método para produção de uma vacina contra o vírus sincicial respiratório (rsv) e ácido nucleico recombinante isolado Download PDF

Info

Publication number
BR112014023195B1
BR112014023195B1 BR112014023195-8A BR112014023195A BR112014023195B1 BR 112014023195 B1 BR112014023195 B1 BR 112014023195B1 BR 112014023195 A BR112014023195 A BR 112014023195A BR 112014023195 B1 BR112014023195 B1 BR 112014023195B1
Authority
BR
Brazil
Prior art keywords
rsv
adenovirus
vaccine
protein
nucleic acid
Prior art date
Application number
BR112014023195-8A
Other languages
English (en)
Portuguese (pt)
Inventor
Katarina Radosevic
Jerôme H. H. V. Custers
Jort Vellinga
Myra N. Widjojoatmodjo
Original Assignee
Janssen Vaccines & Prevention B.V.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Vaccines & Prevention B.V. filed Critical Janssen Vaccines & Prevention B.V.
Priority claimed from PCT/EP2013/055943 external-priority patent/WO2013139916A1/en
Publication of BR112014023195B1 publication Critical patent/BR112014023195B1/pt

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/155—Paramyxoviridae, e.g. parainfluenza virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5256—Virus expressing foreign proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/543—Mucosal route intranasal
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/10011—Adenoviridae
    • C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
    • C12N2710/10341—Use of virus, viral particle or viral elements as a vector
    • C12N2710/10343—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18511—Pneumovirus, e.g. human respiratory syncytial virus
    • C12N2760/18534—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Pulmonology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
BR112014023195-8A 2012-03-22 2013-03-21 vacina contra o vírus sincicial respiratório (rsv), método para produção de uma vacina contra o vírus sincicial respiratório (rsv) e ácido nucleico recombinante isolado BR112014023195B1 (pt)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201261614429P 2012-03-22 2012-03-22
US61/614,429 2012-03-22
EP12160682.6 2012-03-22
EP12160682 2012-03-22
PCT/EP2013/055943 WO2013139916A1 (en) 2012-03-22 2013-03-21 Vaccine against rsv

Publications (1)

Publication Number Publication Date
BR112014023195B1 true BR112014023195B1 (pt) 2021-05-04

Family

ID=52580709

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112014023195-8A BR112014023195B1 (pt) 2012-03-22 2013-03-21 vacina contra o vírus sincicial respiratório (rsv), método para produção de uma vacina contra o vírus sincicial respiratório (rsv) e ácido nucleico recombinante isolado

Country Status (8)

Country Link
KR (1) KR20190107182A (es)
BR (1) BR112014023195B1 (es)
CL (2) CL2014002499A1 (es)
HK (2) HK1206272A1 (es)
IL (2) IL234760A (es)
MX (2) MX351482B (es)
PH (2) PH12014502013B1 (es)
ZA (2) ZA201406892B (es)

Also Published As

Publication number Publication date
KR20190107182A (ko) 2019-09-18
IL234760A (en) 2016-07-31
PH12014502013A1 (en) 2014-11-24
PH12014502013B1 (en) 2014-11-24
PH12014502086B1 (en) 2014-11-24
CL2014002499A1 (es) 2015-01-09
MX2014011340A (es) 2015-05-11
MX351482B (es) 2017-10-03
CL2014002500A1 (es) 2015-01-16
HK1206272A1 (en) 2016-01-08
ZA201406890B (en) 2015-12-23
PH12014502086A1 (en) 2014-11-24
MX352908B (es) 2017-12-13
MX2014011341A (es) 2015-05-11
ZA201406892B (en) 2015-12-23
HK1206274A1 (en) 2016-01-08
IL234758A (en) 2016-07-31

Similar Documents

Publication Publication Date Title
CA2867955C (en) Vaccine against rsv
US11801297B2 (en) Vaccine against RSV
US9119813B2 (en) Vaccine against RSV
BR112014023195B1 (pt) vacina contra o vírus sincicial respiratório (rsv), método para produção de uma vacina contra o vírus sincicial respiratório (rsv) e ácido nucleico recombinante isolado
OA17940A (en) Vaccine against RSV
OA17889A (en) Vaccine against RSV.

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B25D Requested change of name of applicant approved

Owner name: JANSSEN VACCINES AND PREVENTION B.V (NL)

B07E Notice of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B06A Notification to applicant to reply to the report for non-patentability or inadequacy of the application [chapter 6.1 patent gazette]
B25G Requested change of headquarter approved

Owner name: JANSSEN VACCINES AND PREVENTION B.V. (NL)

B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 21/03/2013, OBSERVADAS AS CONDICOES LEGAIS.